Carlos Feijoo-Massó

Dr. Carlos Feijoo-Massó

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Joint Bone Spine
Verified
Journal Article
Open access
PBPilar Brito-Zerón
Pilar Brito-Zerón
RPRoberto Pérez-Alvarez
Roberto Pérez-Alvarez
Carlos Feijoo-MassóCarlos Feijoo-Massó
Carlos Feijoo-Massó
BGBorja Gracia-Tello
Borja Gracia-Tello
AGAndres González-García
Andres González-García
MDM. De-Vicente
M. De-Vicente
To analyze whether immune-mediated diseases (IMDs) occurs in sarcoidosis more commonly than expected in the general population, and how concomitant IMDs influence the clinical presentation of the disease. We searched for coexisting IMDs in patients included in the SARCOGEAS-cohort, a multicenter nationwide database of consecutive patients diagnosed according to the ATS/ESC/WASOG criteria. Comparisons were made considering the presence or absence of IMD clustering, and odds ratios (OR) and their 95% confidence intervals (CI) were calculated as the ratio of observed cases of every IMD in the sarcoidosis cohort to the observed cases in the general population. Among 1737 patients with sarcoidosis, 283 (16%) patients presented at least one associated IMD. These patients were more commonly female (OR: 1.98, 95% CI: 1.49-2.62) and were diagnosed with sarcoidosis at an older age (49.6 vs. 47.5years, P5) were common variable immunodeficiency (CVID) (OR: 431.8), familial Mediterranean fever (OR 33.9), primary biliary cholangitis (OR: 16.57), haemolytic anemia (OR: 12.17), autoimmune hepatitis (OR: 9.01), antiphospholipid syndrome (OR: 8.70), immune thrombocytopenia (OR: 8.43), Sjögren syndrome (OR: 6.98), systemic sclerosis (OR: 5.71), ankylosing spondylitis (OR: 5.49), IgA deficiency (OR: 5.07) and psoriatic arthritis (OR: 5.06). Sex-adjusted ORs were considerably higher than crude ORs for eosinophilic digestive disease in women, and for immune thrombocytopenia, systemic sclerosis and autoimmune hepatitis in men. We found coexisting IMDs in 1 out of 6 patients with sarcoidosis. The strongest associations were found for immunodeficiencies and some systemic, rheumatic, hepatic and hematological autoimmune diseases.

2 July 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MRManuel Ramos-Casals
Manuel Ramos-Casals
RPRoberto Pérez-Alvarez
Roberto Pérez-Alvarez
BKBelchin Kostov
Belchin Kostov
RGRicardo Gómez-De-La-Torre
Ricardo Gómez-De-La-Torre
Carlos Feijoo-MassóCarlos Feijoo-Massó
Carlos Feijoo-Massó
YBYolanda Blanco
Yolanda Blanco
To analyze the frequency and clinical phenotype of neurosarcoidosis (NS) in one of the largest nationwide cohorts of patients with sarcoidosis reported from southern Europe. NS was evaluated according to the Diagnostic Criteria for Central Nervous System and Peripheral Nervous System Sarcoidosis recently proposed by Stern et al. Pathologic confirmation of granulomatous disease was used to subclassify NS into definite (confirmation in neurological tissue), probable (confirmation in extraneurological tissue) and possible (no histopathological confirmation of the disease). Of the 1532 patients included in the cohort, 85 (5.5%) fulfilled the Stern criteria for NS (49 women, mean age at diagnosis of NS of 47.6 years, 91% White). These patients developed 103 neurological conditions involving the brain (38%), cranial nerves (36%), the meninges (3%), the spinal cord (10%) and the peripheral nerves (14%); no patient had concomitant central and peripheral nerve involvements. In 59 (69%) patients, neurological involvement preceded or was present at the time of diagnosis of the disease. According to the classification proposed by Stern et al., 11 (13%) were classified as a definite NS, 61 (72%) as a probable NS and the remaining 13 (15%) as a possible NS. In comparison with the systemic phenotype of patients without NS, patients with CNS involvement presented a lower frequency of thoracic involvement (82% vs 93%, q = 0.018), a higher frequency of ocular (27% vs 10%, q < 0.001) and salivary gland (15% vs 4%, q = 0.002) WASOG involvements. In contrast, patients with PNS involvement showed a higher frequency of liver involvement (36% vs 12%, p = 0.02) in comparison with patients without NS. Neurosarcoidosis was identified in 5.5% of patients. CNS involvement prevails significantly over PNS involvement, and both conditions do not overlap in any patient. The systemic phenotype associated to each involvement was clearly differentiated, and can be helpful not only in the early identification of neurological involvement, but also in the systemic evaluation of patients diagnosed with neurosarcoidosis.

14 August 2018
Verified
Journal Article
Closed access
AFAlejandra Flores-Chávez
Alejandra Flores-Chávez
BKBelchin Kostov
Belchin Kostov
RSRoser Solans
Roser Solans
GFGuadalupe Fraile
Guadalupe Fraile
BMBrenda Maure
Brenda Maure
GRGeas-Ss Semi Registry
Geas-Ss Semi Registry

1 November 2019 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
RPR. Pérez-Alvarez
R. Pérez-Alvarez
PBP. Brito-Zerón
P. Brito-Zerón
BKB. Kostov
B. Kostov
Carlos Feijoo-MassóCarlos Feijoo-Massó
Carlos Feijoo-Massó
GFG. Fraile
G. Fraile
ASA. Sisó-Almirall
A. Sisó-Almirall

1 December 2018 in Joint Bone Spine
Verified
Journal Article
Closed access
AFAndreu Fernández-Codina
Andreu Fernández-Codina
BPBlanca Pinilla
Blanca Pinilla
IPIago Pinal-Fernández
Iago Pinal-Fernández
CLCristina López
Cristina López
GFGuadalupe Fraile-Rodríguez
Guadalupe Fraile-Rodríguez
FMFernando Martínez-Valle
Fernando Martínez-Valle

5 October 2020 in Clinical and Experimental Immunology
Verified
Journal Article
Closed access
PDF file
JOJoaquim Oristrell
Joaquim Oristrell
JLJosé Loureiro‐Amigo
José Loureiro‐Amigo
RSRoser Solans
Roser Solans
MVMa. Pau Valenzuela
Ma. Pau Valenzuela
VMVíctor Monsálvez
Víctor Monsálvez
CTCarles Tolosa
Carles Tolosa